UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6776
Contango Silver & Gold Inc
CTGO
$612M
| $44K | ﹤0.01% |
2,434
-5,724
| -70% | -$117K |
|
6777
Quetta Acquisition Corp
QETA
| $43.9K | ﹤0.01% |
4,245
+4,244
| +424,400% | +$43.7K |
|
6778
ProShares Short High Yield
SJB
$47.8M
| $43.9K | ﹤0.01% |
2,590
-6,789
| -72% | -$117K |
|
|
SYUS
6779
DELISTED
Syntax Stratified U.S. Total Market ETF
SYUS
| $43.8K | ﹤0.01% |
928
+859
| +1,245% | +$40.5K |
|
6780
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.1B
| $43.8K | ﹤0.01% |
+1,083
| New | +$43.8K |
|
6781
Immatics
IMTX
$1.29B
| $43.7K | ﹤0.01% |
3,762
-394
| -9% | -$4.44K |
|
6782
Direxion Daily AMZN Bear 1X ETF
AMZD
$9.86M
| $43.6K | ﹤0.01% |
3,236
+3,136
| +3,136% | +$44.9K |
|
|
ADVM
6783
DELISTED
Adverum Biotechnologies
ADVM
| $43.6K | ﹤0.01% |
6,358
+5,426
| +582% | +$50.5K |
|
6784
Innovator Growth-100 Power Buffer ETF October
NOCT
$228M
| $43.6K | ﹤0.01% |
+889
| New | +$42.7K |
|
|
GRSD
6785
Grandstand Limited Ordinary Shares
GRSD
$67M
| $43.5K | ﹤0.01% |
5,288
-10,120
| -66% | -$85.4K |
|
6786
Stratus Properties
STRS
$158M
| $43.5K | ﹤0.01% |
1,723
-3,892
| -69% | -$91.5K |
|
|
MSB
6787
Mesabi Trust
MSB
$302M
| $43.4K | ﹤0.01% |
2,519
-1,166
| -32% | -$20.2K |
|
|
MGRM
6788
DELISTED
Monogram Orthopaedics
MGRM
| $43.4K | ﹤0.01% |
20,187
+13,680
| +210% | +$30K |
|
6789
Eagle Bancorp Montana
EBMT
$191M
| $43.3K | ﹤0.01% |
3,265
+2,808
| +614% | +$36.3K |
|
6790
Global X 1-3 Month T-Bill ETF
CLIP
$2.58B
| $43.2K | ﹤0.01% |
+430
| New | +$43.1K |
|
6791
Dragonfly Energy
DFLI
$16.7M
| $43.2K | ﹤0.01% |
567
+236
| +71% | +$18.3K |
|
|
EEMD
6792
DELISTED
AAM S&P Emerging Markets High Dividend Value ETF
EEMD
| $43.1K | ﹤0.01% |
2,360
+2,237
| +1,819% | +$41.5K |
|
6793
LiveWire
LVWR
$227M
| $43.1K | ﹤0.01% |
5,628
-13,824
| -71% | -$96.6K |
|
6794
ProShares Nasdaq-100 Dorsey Wright Momentum ETF
QQQA
$69.2M
| $43.1K | ﹤0.01% |
937
+905
| +2,828% | +$39.3K |
|
6795
Taoping
TAOP
$7.35M
| $43.1K | ﹤0.01% |
2,046
+1,872
| +1,076% | +$49.4K |
|
|
AKTX
6796
Akari Therapeutics
AKTX
$14.1M
| $43.1K | ﹤0.01% |
+399
| New | +$29.4K |
|
6797
ReNew
RNW
$2.27B
| $43K | ﹤0.01% |
6,888
+5,501
| +397% | +$33K |
|
|
ACVU
6798
Hartford Alpha Capture Value ETF
ACVU
$183M
| $43K | ﹤0.01% |
1,757
+1,230
| +233% | +$29.9K |
|
6799
Lee Enterprises
LEE
$181M
| $43K | ﹤0.01% |
3,866
+3,816
| +7,632% | +$47.4K |
|
6800
Evogene
EVGN
$8.29M
| $42.9K | ﹤0.01% |
6,601
+351
| +6% | +$2.45K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.